VETO.PA
Price:
$78.7
Market Cap:
$931.15M
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, and dogs. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2006-11-17
Stock Exchange
EURONEXT
Ticker
VETO.PA
According to Vetoquinol SA’s latest financial reports and current stock price. The company's current ROE is 8.81%. This represents a change of 70.49% compared to the average of 5.17% of the last 4 quarters.
The mean historical ROE of Vetoquinol SA over the last ten years is 9.44%. The current 8.81% ROE has changed -6.63% with respect to the historical average. Over the past ten years (40 quarters), VETO.PA's ROE was at its highest in in the June 2021 quarter at 8.83%. The ROE was at its lowest in in the January 2009 quarter at 0%.
Average
9.44%
Median
9.75%
Minimum
5.17%
Maximum
14.25%
Discovering the peaks and valleys of Vetoquinol SA ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 175.52%
Maximum Annual ROE = 14.25%
Minimum Annual Increase = -30.47%
Minimum Annual ROE = 5.17%
Year | ROE | Change |
---|---|---|
2023 | 10.54% | 6.44% |
2022 | 9.90% | -30.47% |
2021 | 14.25% | 175.52% |
2020 | 5.17% | -30.13% |
2019 | 7.40% | -25.90% |
2018 | 9.99% | -3.77% |
2017 | 10.38% | 17.99% |
2016 | 8.79% | 5.37% |
2015 | 8.35% | -13.08% |
2014 | 9.60% | -3.94% |
The current ROE of Vetoquinol SA (VETO.PA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
11.56%
5-year avg
9.45%
10-year avg
9.44%
Vetoquinol SA’s ROE is less than Virbac SA (14.88%), less than Thermador Groupe SA (13.56%), less than Robertet SA (17.78%), less than Trigano S.A. (21.86%), less than Neurones S.A. (13.77%),
Company | ROE | Market cap |
---|---|---|
14.88% | $2.94B | |
13.56% | $657.85M | |
17.78% | $2.03B | |
21.86% | $2.41B | |
13.77% | $1.09B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vetoquinol SA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vetoquinol SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Vetoquinol SA's ROE?
How is the ROE calculated for Vetoquinol SA (VETO.PA)?
What is the highest ROE for Vetoquinol SA (VETO.PA)?
What is the 3-year average ROE for Vetoquinol SA (VETO.PA)?
What is the 5-year average ROE for Vetoquinol SA (VETO.PA)?
How does the current ROE for Vetoquinol SA (VETO.PA) compare to its historical average?